{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T08:44:44Z","timestamp":1794041084989,"version":"4.8.0"},"reference-count":100,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2004,5,14]],"date-time":"2004-05-14T00:00:00Z","timestamp":1084492800000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Dialysis"],"published-print":{"date-parts":[[2004,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Secondary hyperparathyroidism (HPT) is a common complication of chronic kidney disease (CKD) and a frequent cause of clinically significant bone disease. Soft\u2010tissue and vascular calcification, cardiovascular disease, and calcific uremic arteriolopathy (CUA) are additional serious consequences of the disorder that may contribute directly to cardiovascular morbidity and mortality in patients with CKD. Less widely appreciated manifestations include neurological disturbances, hematological abnormalities, and endocrine dysfunction.<\/jats:p><jats:p>\u2003Secondary HPT arises from alterations in calcium, phosphorus, and vitamin D metabolism that develop early in the course of CKD and become more pronounced as kidney function declines. Treatment is often delayed, however, until the disease is well established. Current therapeutic strategies rely largely on the use of vitamin D sterols to diminish excess parathyroid hormone (PTH) synthesis and to lower serum or plasma PTH levels, but their use is often confounded by increases in serum calcium and phosphorus concentrations, changes that can aggravate soft\u2010tissue and vascular calcification. As such, there is a need for new therapeutic interventions that can effectively lower serum or plasma PTH levels without producing untoward side effects.<\/jats:p><jats:p>\u2003The current review summarizes the diverse manifestations of secondary HPT in patients with CKD. The consequences of inadequately controlled secondary HPT and the adverse effects of selected therapeutic interventions for the disorder on vascular calcification and cardiovascular disease in those with CKD are discussed.<\/jats:p>","DOI":"10.1111\/j.0894-0959.2004.17308.x","type":"journal-article","created":{"date-parts":[[2004,5,14]],"date-time":"2004-05-14T12:35:16Z","timestamp":1084538116000},"page":"209-216","source":"Crossref","is-referenced-by-count":78,"title":["The Consequences of Uncontrolled Secondary Hyperparathyroidism and Its Treatment in Chronic Kidney Disease"],"prefix":"10.1111","volume":"17","author":[{"given":"William G.","family":"Goodman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,5,14]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)80977-2"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.0590031187.x"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1993.64"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1990.187"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.11.5249"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00178.x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(97)90484-4"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.2.336"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00575.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.9.2085"},{"key":"e_1_2_5_12_2","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1681\/ASN.V77978","article-title":"Calciphylaxis in chronic renal failure","volume":"7","author":"Budisavljevic MN","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199301213280304"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(97)90330-9"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1976.42"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1159\/000046669"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.29283"},{"key":"e_1_2_5_18_2","first-page":":347","volume-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism.","author":"Goodman W","year":"1999"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.335"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-14-6-690"},{"key":"e_1_2_5_21_2","first-page":"1","article-title":"The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture","volume":"102","author":"Christiansen P","year":"2001","journal-title":"APMIS Suppl"},{"key":"e_1_2_5_22_2","doi-asserted-by":"crossref","first-page":":439","DOI":"10.1093\/oso\/9780192632302.003.0017","volume-title":"The Spectrum of Renal Osteodystrophy.","author":"Goodman W","year":"2001"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80209-3"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.2.233"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.31402"},{"key":"e_1_2_5_26_2","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1681\/ASN.V1291978","article-title":"Adynamic renal osteodystrophy: is there a problem?","volume":"12","author":"Salusky IB","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.50.7.545"},{"key":"e_1_2_5_28_2","first-page":"56","article-title":"Renal osteodystrophy","volume":"6","author":"Sherrard DJ","year":"1986","journal-title":"Semin Nephrol"},{"key":"e_1_2_5_29_2","first-page":"221","article-title":"Aluminum. effects on bone and role in the pathogenesis of renal osteodystrophy","volume":"17","author":"Goodman W","year":"1991","journal-title":"Miner Electrolyte Metab"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1993.323"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1994.380"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199102213240804"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70302-1"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2000.19812"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1994.31"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1998.00875.x"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005183422003"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.7.1014"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1990.293"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(71)90182-3"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-83-3-330"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108326"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.30548"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(88)80237-7"},{"key":"e_1_2_5_45_2","first-page":"160","article-title":"Calcific uremic arteriolopathy in association with low turnover uremic bone disease","volume":"52","author":"Mawad HW","year":"1999","journal-title":"Clin Nephrol"},{"key":"e_1_2_5_46_2","doi-asserted-by":"publisher","DOI":"10.3109\/07853899809002601"},{"key":"e_1_2_5_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199805)185:1<1::AID-PATH89>3.0.CO;2-J"},{"key":"e_1_2_5_48_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116391"},{"key":"e_1_2_5_49_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.21.2168"},{"key":"e_1_2_5_50_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.24533"},{"key":"e_1_2_5_51_2","doi-asserted-by":"publisher","DOI":"10.1038\/386078a0"},{"key":"e_1_2_5_52_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.00803.x"},{"key":"e_1_2_5_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06299-7"},{"key":"e_1_2_5_54_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1976.03630110043012"},{"key":"e_1_2_5_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)52098-4"},{"key":"e_1_2_5_56_2","doi-asserted-by":"publisher","DOI":"10.1159\/000166536"},{"key":"e_1_2_5_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(96)90499-0"},{"key":"e_1_2_5_58_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00375.x"},{"key":"e_1_2_5_59_2","doi-asserted-by":"publisher","DOI":"10.1159\/000168662"},{"key":"e_1_2_5_60_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.4.454"},{"key":"e_1_2_5_61_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1985.71"},{"key":"e_1_2_5_62_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V12102131"},{"key":"e_1_2_5_63_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.29254"},{"key":"e_1_2_5_64_2","first-page":"63","article-title":"Effect of parathyroid hormone on left ventricular diastolic function in patients with primary hyperparathyroidism","volume":"31","author":"Ohara N","year":"1995","journal-title":"Miner Electrolyte Metab"},{"key":"e_1_2_5_65_2","doi-asserted-by":"publisher","DOI":"10.1159\/000170173"},{"key":"e_1_2_5_66_2","doi-asserted-by":"publisher","DOI":"10.1097\/00041552-200105000-00020"},{"key":"e_1_2_5_67_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000038685.95946.83"},{"key":"e_1_2_5_68_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.8.2037"},{"key":"e_1_2_5_69_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.105.2.383"},{"key":"e_1_2_5_70_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.10.1713"},{"key":"e_1_2_5_71_2","first-page":"29","article-title":"Factors modulating cytosolic calcium. Role in lipid metabolism and cardiovascular morbidity and mortality in peritoneal dialysis patients","volume":"17","author":"Gadallah MF","year":"2001","journal-title":"Adv Perit Dial"},{"key":"e_1_2_5_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(97)90212-2"},{"key":"e_1_2_5_73_2","doi-asserted-by":"publisher","DOI":"10.1053\/meta.2000.17708"},{"key":"e_1_2_5_74_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196809262791307"},{"key":"e_1_2_5_75_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196809262791308"},{"key":"e_1_2_5_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70118-6"},{"key":"e_1_2_5_77_2","doi-asserted-by":"publisher","DOI":"10.1159\/000044878"},{"key":"e_1_2_5_78_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110154"},{"key":"e_1_2_5_79_2","doi-asserted-by":"publisher","DOI":"10.1159\/000186596"},{"key":"e_1_2_5_80_2","first-page":"S114","article-title":"Calcium carbonate, an aluminum\u2010free agent for control of hyperphosphatemia, hypocalcemia, and hyperparathyroidism in uremia","volume":"18","author":"Fournier A","year":"1986","journal-title":"Kidney Int"},{"key":"e_1_2_5_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(97)90352-8"},{"key":"e_1_2_5_82_2","doi-asserted-by":"publisher","DOI":"10.1159\/000188742"},{"key":"e_1_2_5_83_2","first-page":"318","article-title":"Prevalence and clinical consequences of elevated Ca \u00d7 P product in hemodialysis patients","volume":"54","author":"Block GA","year":"2000","journal-title":"Clin Nephrol"},{"key":"e_1_2_5_84_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.1998.v32.pm9808141"},{"key":"e_1_2_5_85_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.ndt.a027950"},{"key":"e_1_2_5_86_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00434.x"},{"key":"e_1_2_5_87_2","doi-asserted-by":"publisher","DOI":"10.1038\/366575a0"},{"key":"e_1_2_5_88_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.21.12919"},{"key":"e_1_2_5_89_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.2001.81.1.239"},{"key":"e_1_2_5_90_2","doi-asserted-by":"publisher","DOI":"10.1080\/713782140"},{"key":"e_1_2_5_91_2","first-page":":1019","volume-title":"Principles in Bone Biology.","author":"Nemeth EF","year":"1996"},{"key":"e_1_2_5_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(93)80390-G"},{"key":"e_1_2_5_93_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.7.4040"},{"key":"e_1_2_5_94_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00720.x"},{"key":"e_1_2_5_95_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00183.x"},{"key":"e_1_2_5_96_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000050224.03126.AD"},{"key":"e_1_2_5_97_2","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1681\/ASN.V1341017","article-title":"The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism","volume":"13","author":"Goodman WG","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_5_98_2","doi-asserted-by":"publisher","DOI":"10.1053\/jarr.2002.34841"},{"key":"e_1_2_5_99_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119851"},{"key":"e_1_2_5_100_2","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1681\/ASN.V115903","article-title":"Activation of the calcium receptor by a calcimimetic compound halts the progression of secondary hyperparathyroidism in uremic rats","volume":"11","author":"Chin J","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_5_101_2","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(99)00263-X"}],"container-title":["Seminars in Dialysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0894-0959.2004.17308.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.0894-0959.2004.17308.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T11:37:51Z","timestamp":1705145871000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.0894-0959.2004.17308.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["10.1111\/j.0894-0959.2004.17308.x"],"URL":"https:\/\/doi.org\/10.1111\/j.0894-0959.2004.17308.x","archive":["Portico"],"relation":{},"ISSN":["0894-0959","1525-139X"],"issn-type":[{"value":"0894-0959","type":"print"},{"value":"1525-139X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}